Literature DB >> 26996930

B cells in transplantation.

Esme I Dijke1, Jeffrey L Platt2, Paul Blair3, Menna R Clatworthy4, Jignesh K Patel5, A G Kfoury6, Marilia Cascalho7.   

Abstract

B cell responses underlie the most vexing immunological barriers to organ transplantation. Much has been learned about the molecular mechanisms of B cell responses to antigen and new therapeutic agents that specifically target B cells or suppress their functions are available. Yet, despite recent advances, there remains an incomplete understanding about how B cell functions determine the fate of organ transplants and how, whether or when potent new therapeutics should optimally be used. This gap in understanding reflects in part the realization that besides producing antibodies, B cells can also regulate cellular immunity, contribute to the genesis of tolerance and induce accommodation. Whether non-specific depletion of B cells, their progeny or suppression of their functions would undermine these non-cognate functions and whether graft outcome would suffer as a result is unknown. These questions were discussed at a symposium on "B cells in transplantation" at the 2015 ISHLT annual meeting. Those discussions are summarized here and a new perspective is offered.
Copyright © 2016 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B lymphocytes; accommodation; antibodies; rejection; tolerance

Mesh:

Substances:

Year:  2016        PMID: 26996930      PMCID: PMC4917469          DOI: 10.1016/j.healun.2016.01.1232

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  61 in total

1.  Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation.

Authors:  M L Barr; C J Baker; F A Schenkel; S N McLaughlin; B C Stouch; V A Starnes; E A Rose
Journal:  Clin Transplant       Date:  2000-04       Impact factor: 2.863

2.  The long-term outcome of treated sensitized patients who undergo heart transplantation.

Authors:  Jon A Kobashigawa; Jignesh K Patel; Michelle M Kittleson; Matt A Kawano; Krista K Kiyosaki; Stephanie N Davis; Jaime D Moriguchi; Elaine F Reed; Abbas A Ardehali
Journal:  Clin Transplant       Date:  2010-10-25       Impact factor: 2.863

Review 3.  Accommodation: preventing injury in transplantation and disease.

Authors:  Cody A Koch; Zain I Khalpey; Jeffrey L Platt
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

4.  Bortezomib rescue therapy in a patient with recurrent antibody-mediated rejection after lung transplantation.

Authors:  Christina Baum; Hermann Reichenspurner; Tobias Deuse
Journal:  J Heart Lung Transplant       Date:  2013-09-13       Impact factor: 10.247

5.  Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice.

Authors:  Qing Ding; Melissa Yeung; Geoffrey Camirand; Qiang Zeng; Hisaya Akiba; Hideo Yagita; Geetha Chalasani; Mohamed H Sayegh; Nader Najafian; David M Rothstein
Journal:  J Clin Invest       Date:  2011-08-08       Impact factor: 14.808

6.  Long-term outcome of belatacept therapy in de novo kidney transplant recipients - a case-match analysis.

Authors:  Christoph Schwarz; Sophie Mayerhoffer; Gabriela A Berlakovich; Rudolf Steininger; Thomas Soliman; Bruno Watschinger; Georg A Böhmig; Farsad Eskandary; Franz König; Ferdinand Mühlbacher; Thomas Wekerle
Journal:  Transpl Int       Date:  2015-03-06       Impact factor: 3.782

7.  Transplantation: rituximab induction for prevention of HLA-antibody rebound.

Authors:  Puneet Sood; Sundaram Hariharan
Journal:  Nat Rev Nephrol       Date:  2014-10-07       Impact factor: 28.314

Review 8.  Lessons from cardiac transplantation in infancy.

Authors:  Jeffrey L Platt; Marilia Cascalho; Lori West
Journal:  Pediatr Transplant       Date:  2009-02-20

9.  Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow.

Authors:  Miriam Shapiro-Shelef; Kuo-I Lin; David Savitsky; Jerry Liao; Kathryn Calame
Journal:  J Exp Med       Date:  2005-11-28       Impact factor: 14.307

10.  The significance of studies with transplanted tumours.

Authors:  P A GORER
Journal:  Br J Cancer       Date:  1948-06       Impact factor: 7.640

View more
  8 in total

Review 1.  Accommodation in ABO-incompatible organ transplants.

Authors:  Mayara Garcia de Mattos Barbosa; Marilia Cascalho; Jeffrey L Platt
Journal:  Xenotransplantation       Date:  2018-05       Impact factor: 3.907

Review 2.  Non-canonical B cell functions in transplantation.

Authors:  Jeffrey L Platt; Marilia Cascalho
Journal:  Hum Immunol       Date:  2019-04-10       Impact factor: 2.850

Review 3.  Accommodation and related conditions in vascularized composite allografts.

Authors:  Jeffrey L Platt; Christina L Kaufman; Mayara Garcia de Mattos Barbosa; Marilia Cascalho
Journal:  Curr Opin Organ Transplant       Date:  2017-10       Impact factor: 2.640

4.  Inhibition of B cell-dependent lymphoid follicle formation prevents lymphocytic bronchiolitis after lung transplantation.

Authors:  Natalia F Smirnova; Thomas M Conlon; Carmela Morrone; Peter Dorfmuller; Marc Humbert; Georgios T Stathopoulos; Stephan Umkehrer; Franz Pfeiffer; Ali Ö Yildirim; Oliver Eickelberg
Journal:  JCI Insight       Date:  2019-02-07

5.  Cyclic Helix B Peptide Prolongs Skin Allograft Survival via Inhibition of B Cell Immune Responses in a Murine Model.

Authors:  Long Zheng; Xuanchuan Wang; Linkun Hu; Wenjun Gao; Weitao Zhang; Xuepeng Zhang; Chao Hu; Ruiming Rong; Cheng Yang; Dong Zhu
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

6.  Effect of Immunosuppression on Target Blood Immune Cells Within 1 Year After Lung Transplantation: Influence of Age on T Lymphocytes.

Authors:  Benjamin Coiffard; Matthieu Pelardy; Anderson D Loundou; Corine Nicolino-Brunet; Pascal Alexandre Thomas; Laurent Papazian; Françoise Dignat-George; Martine Reynaud-Gaubert
Journal:  Ann Transplant       Date:  2018-01-05       Impact factor: 1.530

7.  Characterizing pre-transplant and post-transplant kidney rejection risk by B cell immune repertoire sequencing.

Authors:  Silvia Pineda; Tara K Sigdel; Juliane M Liberto; Flavio Vincenti; Marina Sirota; Minnie M Sarwal
Journal:  Nat Commun       Date:  2019-04-23       Impact factor: 14.919

8.  Donor Leukocyte Trafficking and Damage-associated Molecular Pattern Expression During Ex Vivo Lung Perfusion.

Authors:  Robert P Davis; John Yerxa; Qimeng Gao; Jared Gloria; Uwe Scheuermann; Mingqing Song; Min Zhang; William Parker; Jaewoo Lee; Matthew G Hartwig; Andrew S Barbas
Journal:  Transplant Direct       Date:  2020-02-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.